News

Moderna is set to expand its US manufacturing capabilities through the onshoring of drug product manufacturing to its present Moderna Technology Center - MTC located Norwood, Massachusetts, in a move that involves an investment of over $140m. By way of this onshoring,...

The Australian-based biopharma company, CSL, plans to invest almost $1.5 billion in the next five years so as to expand its presence in the U.S. However, this is going to be subject to the approval from the board of...

The news of Pfizer to acquire Metsera in a $10bn deal has indeed caught the eye of many. Metsera happens to be a US-based biotechnology firm and the deal was indeed a result of a heated bidding battle against...

European venture capital firm Sofinnova Partners said on November 17 that it raised 650 million euros, equivalent to $750 million, for a new fund that is going to support the present and upcoming life sciences companies. It is well to be...

Johnson & Johnson will be paying $3.05 billion so as to acquire Halda Therapeutics, thereby getting a novel cell death platform while at the same time also strengthening its prostate cancer franchise that’s built on Erleada. At the mainstay of the...

An analysis by BCC Research shows that the market for analytical laboratory instruments will grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028, rising from $60.9 billion in 2023 to $82.5 billion by 2028. The...

In recent years, dietary supplements have become a major part of many people’s daily routines. From multivitamins and protein powders to herbal extracts and minerals, supplements are used to support health, fill nutritional gaps, and enhance overall wellbeing. However,...